Search Results - "Pierre Dayer"

Refine Results
  1. 1

    Drug-Induced Long QT in Adult Psychiatric Inpatients: The 5-Year Cross-Sectional ECG Screening Outcome in Psychiatry Study by R. Girardin, François, Gex-Fabry, Marianne, Berney, Patricia, Shah, Dipen, Gaspoz, Jean-Michel, Dayer, Pierre

    Published in The American journal of psychiatry (01-12-2013)
    “…Routine electrocardiograms of 6,790 patients admitted to a Swiss public psychiatric hospital over 5 years showed the likelihood of a long QT interval increases…”
    Get full text
    Journal Article
  2. 2

    Patented drug extension strategies on healthcare spending: a cost-evaluation analysis by Vernaz, Nathalie, Haller, Guy, Girardin, François, Huttner, Benedikt, Combescure, Christophe, Dayer, Pierre, Muscionico, Daniel, Salomon, Jean-Luc, Bonnabry, Pascal

    Published in PLoS medicine (01-06-2013)
    “…Drug manufacturers have developed "evergreening" strategies to compete with generic medication after patent termination. These include marketing of slightly…”
    Get full text
    Journal Article
  3. 3

    CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis by VUILLEUMIER, Nicolas, ROSSIER, Michel F, CHIAPPE, Alberto, DEGOUMOIS, Florence, DAYER, Pierre, MERMILLOD, Bernadette, NICOD, Laurent, DESMEULES, Jules, HOCHSTRASSER, Denis

    Published in European journal of clinical pharmacology (01-06-2006)
    “…To determine whether pharmacogenetic tests such as N-acetyltransferase 2 (NAT2) and cytochrome P450 2E1 (CYP2E1) genotyping are useful in identifying patients…”
    Get full text
    Journal Article
  4. 4

    Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers by Ancrenaz, Virginie, Déglon, Julien, Samer, Caroline, Staub, Christian, Dayer, Pierre, Daali, Youssef, Desmeules, Jules

    Published in Basic & clinical pharmacology & toxicology (01-02-2013)
    “…The new anti‐aggregating agent prasugrel is bioactivated by cytochromes P450 (CYP) 3A and 2B6. Ritonavir is a potent CYP3A inhibitor and was shown in vitro as…”
    Get full text
    Journal Article
  5. 5

    Impact of Advance Directives and a Health Care Proxy on Doctors' Decisions: A Randomized Trial by Escher, Monica, MD, Perneger, Thomas V., MD, Rudaz, Sandrine, MA, Dayer, Pierre, MD, Perrier, Arnaud, MD

    “…Abstract Context Advance directives or proxy designations are widely recommended, but how they affect doctors' decision making is not well known. Objectives…”
    Get full text
    Journal Article
  6. 6

    Doctors' Decisions When Faced With Contradictory Patient Advance Directives and Health Care Proxy Opinion: A Randomized Vignette-Based Study by Escher, Monica, MD, Perrier, Arnaud, MD, Rudaz, Sandrine, MA, Dayer, Pierre, MD, Perneger, Thomas V., MD

    Published in Journal of pain and symptom management (01-03-2015)
    “…Abstract Context Sometimes a written advance directive contradicts the opinion of a health care proxy. How this affects doctors' decision making is unknown…”
    Get full text
    Journal Article
  7. 7

    Role of P‐glycoprotein in the Uptake/Efflux Transport of Oral Vitamin K Antagonists and Rivaroxaban through the Caco‐2 Cell Model by Gschwind, Liliane, Rollason, Victoria, Daali, Youssef, Bonnabry, Pascal, Dayer, Pierre, Desmeules, Jules Alexandre

    Published in Basic & clinical pharmacology & toxicology (01-10-2013)
    “…Vitamin K antagonists (VKAs) are prescribed worldwide and remain the oral anticoagulant of choice. These drugs are characterized by a narrow therapeutic index…”
    Get full text
    Journal Article
  8. 8

    Pharmacogenetics of analgesics: toward the individualization of prescription by Rollason, Victoria, Samer, Caroline, Piguet, Valerie, Dayer, Pierre, Desmeules, Jules

    Published in Pharmacogenomics (01-07-2008)
    “…The use of analgesics is based on the empiric administration of a given drug with clinical monitoring for efficacy and toxicity. However, individual responses…”
    Get more information
    Journal Article
  9. 9

    Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements by Besson, Marie, MD, Samer, Caroline, MD, PharmD, Rollason, Victoria, PharmD, Dayer, Pierre, MD, Desmeules, Jules, MD

    Published in Clinical therapeutics (01-07-2015)
    “…Abstract Quality therapeutics play an important role in Switzerland’s health care and economy. Switzerland holds a key position in the world of research and…”
    Get full text
    Journal Article
  10. 10

    Transcriptional regulation of CYP2C19 and its role in altered enzyme activity by Uppugunduri, Chakradhara Rao S, Daali, Youssef, Desmeules, Jules, Dayer, Pierre, Krajinovic, Maja, Ansari, Marc

    Published in Current drug metabolism (01-10-2012)
    “…Cytochrome P450 2C19 (CYP2C19) is involved in the metabolism of several drugs that are currently in clinical use. The gene encoding CYP2C19 is polymorphic with…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13

    Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers by Ing Lorenzini, Kuntheavy, Besson, Marie, Daali, Youssef, Salomon, Denis, Dayer, Pierre, Desmeules, Jules

    Published in Chimia (01-01-2012)
    “…A pharmacokinetic/pharmacodynamic, randomized, crossover, placebo-controlled study was conducted in healthy human volunteers with the primary objective of…”
    Get full text
    Journal Article
  14. 14

    A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes by Jerdi, Mallorie Clement, Daali, Youssef, Oestreicher, Mitsuko Kondo, Cherkaoui, Samir, Dayer, Pierre

    “…An efficient, fast and reliable analytical method was developed for the simultaneous evaluation of the activities of five major human drug metabolising…”
    Get full text
    Journal Article
  15. 15

    A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin by Ferguson, R J, De Morais, S M, Benhamou, S, Bouchardy, C, Blaisdell, J, Ibeanu, G, Wilkinson, G R, Sarich, T C, Wright, J M, Dayer, P, Goldstein, J A

    “…The 4'-hydroxylation of the S-enantiomer of the anticonvulsant drug mephenytoin exhibits a genetic polymorphism in humans. This polymorphism shows marked…”
    Get more information
    Journal Article
  16. 16

    Two-dimensional liquid chromatography–ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma by Ing-Lorenzini, Kuntheavy R., Desmeules, Jules A., Besson, Marie, Veuthey, Jean-Luc, Dayer, Pierre, Daali, Youssef

    Published in Journal of Chromatography A (01-05-2009)
    “…A bioanalytical method was developed for the simultaneous determination of paracetamol and ketorolac enantiomers in human plasma using two-dimensional liquid…”
    Get full text
    Journal Article
  17. 17

    In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (+/-)-fluvastatin by Transon, C, Leemann, T, Vogt, N, Dayer, P

    Published in Clinical pharmacology and therapeutics (01-10-1995)
    “…(+/-)-Fluvastatin is a synthetic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that selectively and competitively inhibits P450TB…”
    Get more information
    Journal Article
  18. 18

    Metabolic genetic polymorphisms and susceptibility to lung cancer by Bouchardy, Christine, Benhamou, Simone, Jourenkova, Nadejda, Dayer, Pierre, Hirvonen, Ari

    Published in Lung cancer (Amsterdam, Netherlands) (01-05-2001)
    “…Activity of some enzymes implicated in the metabolism of tobacco carcinogens presents a great variability between individuals due to the existence of a…”
    Get full text
    Journal Article
  19. 19

    Glutathione S-Transferase GSTM3 and GSTP1 Genotypes and Larynx Cancer Risk by Jourenkova-Mironova, N, Voho, A, Bouchardy, C, Wikman, H, Dayer, P, Benhamou, S, Hirvonen, A

    “…Glutathione S -transferases (GSTs) are involved in detoxification of reactive metabolites of carcinogens and, therefore, could be potentially important in…”
    Get full text
    Journal Article
  20. 20

    Admission to intensive care: A qualitative study of triage and its determinants by Escher, Monica, Cullati, Stéphane, Hudelson, Patricia, Nendaz, Mathieu, Ricou, Bara, Perneger, Thomas, Dayer, Pierre

    Published in Health services research (01-04-2019)
    “…Objective To examine physicians’ decision making and its determinants about admission to intensive care. Data Sources/Study Setting ICU physicians (n = 12) and…”
    Get full text
    Journal Article